| 摘要 |
The present invention relates to pharmaceutical compositions comprising aspirin and atorvastatin and/or their pharmaceutically acceptable salts, hydrates, enantiomers, racemates, organic salts, inorganic salts, esters, polymorphs, crystal forms and amorphous forms and/or combinations thereof in order to be used in the treatment and prophylaxis of cardiovascular diseases. |
